Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the ...
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the ...
Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...
On Monday, Instacart (CART) stock saw a decline, ending the day at $45.65 which represents a decrease of $-0.34 or -0.74% from the prior close of $45.99. The stock opened at $45.17 and touched a low ...
BTIG research firm reiterated its Buy rating and $21.00 price target for INmune Bio Inc. (NASDAQ:INMB), currently trading at ...
FTAI Aviation Ltd (FTAI) stock saw a modest uptick, ending the day at $91.65 which represents a slight increase of $0.67 or 0.74% from the prior close of $90.98. The stock opened at $89.8 and touched ...
Papa Johns’ blueprint under CEO Todd Penegor has several targets, from a return to core strength focus to data leverage to ...
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12th Annual BTIG MedTech, Digital Health, ...
BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...
BTIG initiated coverage of Arcturus Therapeutics (ARCT) with a Buy rating and $41 price target Arcturus is a commercial-stage biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback